Weekly Urticaria Activity Score (UAS7) and Dermatology Life Quality Index (DLQI) in Validation of Chronic Spontaneous/Idiopathic Urticaria (CSU/CIU) Health States
Sam Khalil(Novartis (Switzerland)), Donald E. Stull(IQVIA (United States)), Clive Grattan(Guy's Hospital), Doreen McBride(University College London), Ana M. Giménez‐Arnau(Universitat Pompeu Fabra), Maria‐Magdalena Balp(Novartis (Switzerland))
Cited by 20
Related Papers
The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
|Allergy|2018|1.5k
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
|Allergy|2021|1.2k
Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria
|New England Journal of Medicine|2013|1.1k